Clinical Trials Logo

Blood Glucose clinical trials

View clinical trials related to Blood Glucose.

Filter by:

NCT ID: NCT06382506 Completed - Obesity Clinical Trials

The Effect of Hazelnut Flour on Blood Glucose

Hazelnut
Start date: March 21, 2024
Phase: N/A
Study type: Interventional

One of the factors affecting human health is nutrition. The effects of foods on blood glucose are still under investigation. The Glycemic Index (GI), which is associated with many diseases today, is a value that measures the rate at which carbohydrate-containing foods raise blood glucose. It is thought that the loaves of bread produced will be a product with low GI value and can be consumed by celiacs and diabetics. It is aimed to investigate the effect of adding different amounts of hazelnut flour to bread recipes using gluten-free corn flour on blood glucose.

NCT ID: NCT06288178 Completed - Obesity Clinical Trials

The Effect of Consumption of Bread Types Made From Various Flours on Blood Glucose Fluctuations

Obesity
Start date: December 19, 2022
Phase: N/A
Study type: Interventional

The obesities were aimed at the effect of whole wheat (WWB), buckwheat (BWB), and cornbread (CB) on blood glucose by comparing the glycemic index values with reference bread (RB). Overall, WWB consumption had a positive effect on blood glucose in individuals with obesity, while BWB consumption caused an increase in blood glucose levels.

NCT ID: NCT05976633 Completed - Blood Glucose Clinical Trials

Glycemic Response to Wild Rice and Wild Rice Blends in Humans Study

EFGW
Start date: July 14, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the effects of wild rice and wild rice blends compared to other rice on glycemic control and evaluating factors that influence glycemic response to wild rice in healthy individuals. The main questions aim to answer: 1. Is there an effect of wild rice on blends on glycemic control and response? 2. Does cooking wild rice via stovetop or microwave change its glycemic response? 3. Is the wild rice blend product palatable? 4. What is the subjective appetite when consuming the treatment? Participants will: - consent to attend 5 study visits being 2.5 hours each - come to each visit fasted for at least 10-12 hours. - complete a Motivation to Eat VAS following each blood measure

NCT ID: NCT05961475 Recruiting - Blood Glucose Clinical Trials

Monitoring Postprandial Glycemia in Fruit Snacks

Start date: June 22, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the postprandial glucose and insulin responses after different fruit snack consumption in a healthy population.

NCT ID: NCT05750316 Recruiting - Blood Glucose Clinical Trials

Impact of Consumption of Cowpea Leaves on Blood Glucose

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Intake of foods high in carbohydrates causes a spike in glucose in the blood. Repeated high blood glucose spikes are associated with an increased risk of diabetes. Polyphenols, which are abundant in vegetables, may influence how the body utilises carbohydrates. Cowpea, also referred to as black-eyed peas (Vigna unguiculata (L.) Walp.) leaves, contain polyphenols and fibre that can help regulate blood glucose. The study will be an acute, single-blind, randomised control trial with a cross-over design involving healthy black participants aged ≥18 years. This clinical trial aims to investigate if consuming cowpea leaves can reduce blood glucose spikes after consuming a meal high in carbohydrates. Participants will be randomised to consume either bread with jam containing freeze-dried cowpea leaves (active intervention) or jam without any freeze-dried powder (control group). Blood glucose will be monitored before the intervention and every 15 minutes after the intervention using a continuous glucose monitor.

NCT ID: NCT05585801 Recruiting - Critical Care Clinical Trials

Continuous Glucose Monitoring in Intensive Care Unit

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Glucose control in ICU patients is challenging and exerts high burden on the nursing staff. Continuous glucose monitors (CGM) are now approved and widely available in the outpatient setting for patients with diabetes mellitus. However, only minimal evidence on CGM performance, reliability and benefit in achieving desired glucose control in the intensive care setting has been gathered so far. The objective of this study is to assess whether the use of CGM helps to maintain blood glucose levels within the time in range recommended for patients in the intensive care. In addition, accuracy of the sensor will be evaluated and compared to measurements of blood glucose by standardized biochemistry methods.

NCT ID: NCT05573607 Completed - Blood Glucose Clinical Trials

Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life

Start date: November 19, 2020
Phase: N/A
Study type: Interventional

This study is a double-blind, randomized, two-arm, placebo-controlled trial of apparently healthy men and women to be recruited at a single investigational center in Northeast Ohio (i.e. The Center for Applied Health Sciences). Subjects will attend four study visits. During Visit 1, subjects will be screened for participation (i.e., medical history, physical exam, routine blood work [also HgA1c, insulin], background baseline diet). Over the next 12 weeks, subjects will attend Visits 2-4, wherein assessments of serum glucose, insulin, HOMA-IR, 2-hour glucose tolerance test (GTT), HgA1c, C-reactive protein, adiponectin, ferritin, waist circumference, quality of life questionnaire, and various visual analog scales for appetite, satiety, and cravings will be made.

NCT ID: NCT05397509 Recruiting - Blood Glucose Clinical Trials

Effect of the Olive Leaf Tea Ingestion in Post-prandial Glycemic Response (OLIFTEA)

OLIFTEA
Start date: April 29, 2022
Phase: N/A
Study type: Interventional

This study tests the effect of Olive Tea Ingestion in ameliorating glycemic response after a high-glycemic meal

NCT ID: NCT05396079 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effect of Tahini in Oxidative Stress and Endothelial Function in Diabetes

Start date: March 28, 2023
Phase: N/A
Study type: Interventional

Cardiovascular disease (CVD), a cluster of disorders that affect heart and blood vessels, is the leading cause of morbidity and mortality around the world and is responsible for 17.9 million deaths annually worldwide. CVD risk factors can be modifiable (nutrition, physical activity, obesity, smoking, hyperlipidemia, hypertension and diabetes) and non-modifiable (age, gender, ethnicity, family history and socioeconomic status). Chronic exposure to CVD risk factors induces oxidative stress and promotes inflammation. In addition, endothelial cells in response to the inflammatory reaction secrete growth factors, leading to the destruction of vascular endothelium and promoting atherogenesis. Oxidative stress refers to the imbalance between anti-oxidant and pro-oxidant compounds, with predominance of the pro-oxidant ones. Reactive Oxygen Species overproduction has been implicated in pathogenesis and complications of numerous diseases including diabetes, cardiovascular diseases, cancer, neurodegenerative diseases and chronic kidney disease. Moreover, endothelium consists of a single layer of endothelial cells; it is the natural barrier between blood and tissues and also an endocrine organ. It plays a key role in vascular homeostasis by maintaining a balance between vasodilation and vasoconstriction and is responsible for fluid filtration, blood vessel tone, hormone trafficking, hemostasis, regulation of blood flow and growth of blood vessels. Thus, reductions in endothelial function are detrimental and predict and precede the development of overt CVD. Sesame belongs to Pedaliaceae family and can be consumed in different forms such as seeds, oil or tahini, i.e., a 100 % peeled, ground and roasted sesame paste. Tahini is rich in polyunsaturated fatty acids, proteins, vitamin E and lignans, such as sesamin, sesamolin and sesamol. Recent studies have indicated that tahini consumption can lower blood pressure and pulse rate and improve endothelial function and glycemic response in healthy males postprandially. However, only two studies are available in the current literature concerning the effect on diabetes, one of them in patients with type 2 diabetes and one in diabetic animal model. Thus, the aim of the present study is to investigate the effect of tahini consumption on oxidative stress, blood pressure, endothelial function and arterial stiffness in patients with type 2 diabetes postprandially.

NCT ID: NCT05352724 Completed - Microbiota Clinical Trials

Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise

Start date: October 20, 2022
Phase: N/A
Study type: Interventional

Although the general effectiveness of carbohydrate/electrolyte-based functional sports drinks on rehydration, recovery and sports performance has been widely demonstrated, there is controversy about the amounts, proportions and components that ensure the effectiveness of these products. The present study intends to analyze the specific effects of the beverages to be studied on these parameters, taking into account their particular formulation. Advances in research have allowed us to understand the importance of the intestinal microbiota on health, recovery and performance in sports. The consumption of functional drinks based on carbohydrates and electrolytes as supplementation is a constant in sports environments, with multiple studies on their properties, tolerance, safety and efficacy. However, there are no studies that analyze the effects of consuming these beverages and their interaction with the intestinal microbiota. Therefore, in addition, it is intended to evaluate the changes in the microbiota, through analysis of stool samples, during the sustained consumption of the beverages under study.